Wendt Daniel, Thielmann Matthias, Melzer Andreas, Benedik Jaroslav, Droc Ionel, Tsagakis Konstantinos, Dohle Daniel S, Jakob Heinz, Abele John E
Department of Thoracic and Cardiovascular Surgery, West German Heart Center Essen, University Hospital Essen, Germany.
Minim Invasive Ther Allied Technol. 2013 Aug;22(4):242-53. doi: 10.3109/13645706.2013.822396.
Cardiovascular disease is a leading cause of death in all developed countries. In response to this need, endovascular management techniques have been developed across a large range of medical specialties. Minimally invasive percutaneous interventions were initially complex and challenging, but with the continued development of equipment and expertise their use has become routine in many fields. With routine use, it has become important to establish the safety and efficacy of endovascular treatments against the respective "gold standard" procedures, especially in light of their initial intended use for the management of patients at unacceptably high risk for standard therapy only. Such evaluation has to take into account the variety and diversity of devices and techniques, as well as the effects of operator dependability. Endovascular techniques are increasingly recognised as valid alternative management options for a variety of conditions, and it is anticipated that the current trend towards minimally invasive techniques will continue in the future, with moves towards increasingly complex endovascular techniques and hybrid interventions.
心血管疾病是所有发达国家的主要死因。为满足这一需求，血管内治疗技术已在众多医学专科中得到发展。微创经皮介入治疗最初复杂且具有挑战性，但随着设备和专业技术的不断发展，其在许多领域的应用已成为常规操作。随着常规使用，对照各自的“金标准”程序确立血管内治疗的安全性和有效性变得很重要，特别是鉴于它们最初旨在用于管理仅接受标准治疗风险高得不可接受的患者。这种评估必须考虑到设备和技术的多样性，以及操作者可靠性的影响。血管内技术越来越被认为是多种病症的有效替代治疗选择，预计未来微创技术的当前趋势将持续下去，朝着越来越复杂的血管内技术和混合干预发展。
